-
Optimal framework for the state regulation of hemp cannabinoids
The hemp cannabinoid market has grown into a $3 billion interstate industry.
-
New Mexico Senate Bill 219 would regulate medical psilocybin access
The Medical Psilocybin Act would create a regulated system to allow patients with qualifying conditions to access and use psilocybin.
-
-
28th Annual Highway Report: Executive summary of findings and state rankings
The Annual Highway Report examines every state's road pavement and bridge conditions, traffic fatalities, congestion delays, spending per mile, administrative costs, and more.
-
Transportation revenue options in Maryland
Maryland needs to replace the fuel tax with a new more sustainable revenue source.
-
The Florida Retirement System’s proposed cost-of-living adjustment comes with major costs and risks
The cost-of-living adjustment proposed in Florida House Bill 945 could cost taxpayers over $47 billion over 30 years.
-
Addressing the transit productivity crisis
Public transit ridership is unlikely to recover to pre-pandemic levels within the next decade.
-
House Bill 78 exposes Alaska to significant additional costs
This bill could realistically add $11.4 billion in additional costs to future state budgets and reintroduce Alaska to significant pension risk.
-
Arizona Senate Bill 1365 threatens higher taxpayer costs and pension risks
Arizona Public Safety Personnel Retirement System Tier 3 reform is working. Senate Bill 1365 would fundamentally alter the current system.
-
Legalizing psilocybin access in Arizona would benefit mental health
Arizona Senate Bill 1555 would create a regulatory framework for limited, legal access to therapeutic psilocybin services.
-
Delaware Senate Bill 46 would ban autonomous vehicles
Automated vehicle technology under development could greatly improve road safety and efficiency.
-
Tennessee Senate Bill 310 would prohibit driverless vehicles
Automated vehicle technology could greatly improve road safety and efficiency.
-
Psychedelic treatment for neurodegenerative disorders
Recent research suggests that psychedelics, such as psilocybin and LSD, show strong potential as effective treatments for neurodegenerative disorders.